Combination of T-DM1 and platinum-based chemotherapy in patient-derived xenograft models of muscle-invasive bladder cancer

OBJECTIVE(S): To assess the efficacy and safety of T-DM1, as an anti-HER2 antibody-drug conjugate (ADC), alone and in combination with two platinum-based chemotherapy regimens in patient-derived xenografts (PDXs) of muscle-invasive bladder cancer (MIBC) established in immunodeficient mice. MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Razzaghdoust, Abolfazl, Muhammadnejad, Samad, Parvin, Mahmoud, Bahram, Bahram, Zangeneh, Masoumeh, Basiri, Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392562/
https://www.ncbi.nlm.nih.gov/pubmed/36033955
http://dx.doi.org/10.22038/IJBMS.2022.63509.14005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392562/
https://www.ncbi.nlm.nih.gov/pubmed/36033955
http://dx.doi.org/10.22038/IJBMS.2022.63509.14005

Ejemplares similares